Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice
使用 caspase-1 抑制剂进行干预可降低 LDLR-/-.Leiden 小鼠的肥胖相关高胰岛素血症、非酒精性脂肪性肝炎和肝纤维化
期刊:International Journal of Obesity
影响因子:
doi:10.1038/ijo.2016.74
M C Morrison, P Mulder, K Salic, J Verheij, W Liang, W van Duyvenvoorde, A Menke, T Kooistra, R Kleemann, P Y Wielinga